Aramark's Long-Term Contracts Make It A Reliable Hold

Aramark (ARMK) reported robust FY2024 results with $17.4 billion revenue (+8%) and strong Q2 2025 performance, including a 35% increase in adjusted EPS and 98% client retention, leading to optimistic FY2025 guidance of 7.5-9.5% organic sales growth and 23-28% adjusted EPS growth. The company's stable, contract-based business model, essential services, and a $500 million share repurchase plan highlight its operational strength and management confidence. While Aramark's valuation is in line with steady growth and it has outperformed the S&P 500, a significant debt load of $6.84 billion and thin margins remain key considerations, prompting a 'wait-and-hold' stance ahead of Q3 earnings on August 5th given the current fair valuation.

Analysis

Aramark's financial profile presents a compelling case of operational stability balanced by significant financial leverage. The company's core business model, centered on long-term contracts for essential services, is validated by a high client retention rate of 98% in Q2 2025 and new contract wins. This stability translated into record FY 2024 revenue of $17.4 billion, an 8% year-over-year increase, and strong Q2 2025 results featuring a 35% rise in adjusted EPS. Management has issued confident guidance for FY2025, forecasting organic sales growth of 7.5-9.5% and adjusted EPS growth of 23-28%, further supported by a $500 million share repurchase program. However, this positive outlook is tempered by a substantial debt load of $6.84 billion and characteristically thin industry profit margins. The stock's valuation reflects this dichotomy; its forward P/E of 18.82x is reasonable compared to high-multiple peers like Cintas but offers no clear discount, suggesting the market has already priced in the expected growth. The primary risk remains the high leverage, which could be exacerbated by persistent high interest rates or an economic downturn.

Key Decisions for Investors

• Investors should monitor the upcoming Q3 2025 earnings release on August 5 for confirmation that the company is meeting its strong guidance, particularly regarding adjusted EPS growth and margin expansion, before initiating or adding to a position.
• Given the significant $6.84 billion debt load, it is critical to scrutinize management's commentary on deleveraging progress, as this is a primary risk factor impacting the company's long-term financial health and earnings quality.
• The current valuation appears fair rather than undervalued, suggesting that while the stock may suit long-term holders benefiting from steady growth and capital returns, new investors should exercise patience as the risk/reward profile does not indicate a compelling entry point at this time.